Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,478,404
-
Share change
-
-414,134
-
Total reported value
-
$98,566,489
-
Put/Call ratio
-
616%
-
Price per share
-
$39.75
-
Number of holders
-
64
-
Value change
-
-$16,603,407
-
Number of buys
-
25
-
Number of sells
-
21
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2023
As of 30 Sep 2023,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,478,404 shares.
The largest 10 holders included
Clal Insurance Enterprises Holdings Ltd, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, WELLS FARGO & COMPANY/MN, Gladstone Institutional Advisory LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, FIRST CITIZENS BANK & TRUST CO, and Royal Bank of Canada.
This page lists
64
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.